Transdermal Drug Delivery System Market Size and Forecasts (2020-2030)
Transdermal Drug Delivery System Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Transdermal Patches, Transdermal Gel, Transdermal Sprays, and Others), Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications, and Other Applications), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
$3,185 – $5,985
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
The key factors driving the market’s growth include growing areas of application of transdermal drug delivery systems and rising cases of spinal cord injury. However, the post-surgical complications hinder the market growth.
Market Opportunities of Transdermal Drug Delivery Systems Market
A transdermal drug administration route is novel and one of the reliable means of sustained drug delivery. With significant research being conducted in this field and the increasing interest of researchers in this form of drug delivery, a large number of transdermal patches are likely to reach the marketplace in the future. Transdermal patches are used to deliver drugs such as nicotine, fentanyl, nitroglycerin, and clonidine to treat various medical conditions. Recently, these patches have been explored to deliver biologics in various applications. Smart patches are equipped with sensors and other technologies to monitor patient conditions and adjust drug delivery accordingly. In January 2023, a lead scientist at Swansea University developed a new smart patch to detect proinflammatory biomarkers of neurodegenerative diseases such as Parkinson’s and Alzheimer’s using the microneedle technology. These smart patches comprise numerous microneedles designed to penetrate the skin barrier in a minimally invasive manner, followed by monitoring the biomarkers of clinical significance. They can be self-administered for point-of-care diagnosis at general practices or at home. This innovative research can potentially change the landscape of early neurodegenerative disease detection.
According to an article titled “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery,” published in the National Library of Medicine in November 2021, personalized 3D-printed patches that conform to the skin surface can be used for acetyl-hexapeptide 3 (AHP-3) delivery. In this study, two liquid monomers—polyethylene glycol diacrylate (PEGDA) and vinylpyrrolidone (VP)—were used in different proportions to improve the mechanical strength, polymerization rate, and swelling rate of the final polymer. Optimal drug loading on the resin indicated that AHP-3 remained stable throughout the manufacturing process and had no effect on the physical properties of the final polymer. Using a 3D scanned facial model, a personalized patch was designed in computer-aided design software, and it was fabricated in optimized resin using a digital light processing 3D printer. The in-vitro characterization of prepared transdermal patches has shown their ability to penetrate human cadaver skin, further remaining intact upon compression. “3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery” is the first study demonstrating personalized patches made using photopolymers, and it has introduced a novel approach to improve the transdermal delivery of drugs for effective wrinkle management.
Thus, the adoption of 3D printing technology and smart patches is likely to offer opportunities to the transdermal drug delivery systems market in the coming years.
Factors Hampering Transdermal Drug Delivery Systems Market
Currently marketed transdermal drug delivery systems (TDDS), transmucosal drug delivery systems (TMDS), and topical patches may retain 10–95% of the initial total quantity of the drug as a residual drug after the intended use period. This raises a potential safety issue for patients, and their family members and caregivers. For example, adverse events due to a patient’s failure to remove TDDS at the end of the intended use period generally result in an increased or prolonged pharmacological effect of the drug. Some children have also been reported to have died from accidental exposure to discarded TDDS. Below are some of the product recalls and withdrawals by the manufacturers.
In February 2023, Aveva Drug Delivery Systems Inc recalled two lots of buprenorphine transdermal systems for failing to meet impurity/degradation specifications. Aveva Drug Delivery Systems voluntarily initiated the recall on February 15, 2023, which was designated as a Class III recall by the FDA on March 14, 2023. Under this recall classification, the use of the product is not likely to cause any major harm. In September 2020, Teva Pharmaceuticals USA recalled two lots of buprenorphine patches. The recall affected 32,543 cartons of buprenorphine transdermal systems, 5 mcg/hour, four transdermal systems per carton (patch NDC 0093-3656-21, carton NDC 0093-3656-40), from lots 190017 and 190161. The product was manufactured by 3M Drug Delivery Systems for Teva Pharmaceuticals and distributed in the US and Puerto Rico. Followed by its voluntary recall by Teva Pharmaceuticals on September 4, 2020, the FDA designated the recall Class II on October 1, 2020. Continuing the use of Class II recall products may cause temporary or medically reversible adverse health consequences if used. While remote, a possibility of serious harm exists. Further, in April 2018, the FDA sent a Warning Letter to Phase 4 Pharmaceutical LLC. Instead of manufacturing transdermal drug types, the firm was functioning as a re-packager of over-the-counter (OTC) transdermal drug types, and the FDA found several violations of CGMP that affected the quality of its products. In April 2019, Alvogen, Inc. announced a voluntary, nationwide recall of two lots (or batches) of Fentanyl Transdermal System, 12 mcg/h transdermal patches, because of a label mix-up. Thus, adverse effects and recalls of transdermal drug delivery systems hinder the market growth.
Transdermal Drug Delivery Systems Market: Segmental Overview
Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022–2030. A transdermal patch is a drug delivery system attached to a patient’s skin to deliver medication through the skin.
The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application. The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. Central nervous system disorders segment is expected to register the highest CAGR in the market during 2022–2030.
Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022–2030.
Transdermal Drug Delivery Systems Market: Geographical Overview
North America accounted for the largest share of the global transdermal drug delivery systems market in 2022. In the region, the US held the largest transdermal drug delivery systems market share and is anticipated to register the highest CAGR during 2022-2030. According to the American Heart Association (AHA), cardiovascular disease (CVD) remains the leading cause of death in the US. According to the CDC, in 2021, CVD accounted for ~695,000 deaths and ~1 in 5 deaths in the US. The rising prevalence of cardiovascular disease, diabetes, chronic pain conditions, and other chronic diseases drives the demand for effective and convenient treatment options. Medical patches offer a noninvasive and patient-friendly approach to deliver medication and manage symptoms associated with these chronic conditions. Ongoing advancements in TDDS, such as wearable sensors and flexible electronics, contribute to the growth of the transdermal drug delivery system market. These advancements allow for more accurate dosing, enhanced patient monitoring, and improved patient compliance. According to a report titled “Recent advances in transdermal drug delivery systems,” published by Biomaterials Research in 2021, microneedles attract significant attention among TDDS modalities, which overcome the limitations of the existing simple application type and patch-type needles by combining the advantages of microneedles to obtain higher treatment efficiency and effects. Advances in these TDDS can provide the driving force for controlling the prevalence of cardiovascular and central nervous system diseases, diabetes, neuromuscular diseases, and infectious and localized infectious diseases.
The growing trend of personalized medicines, where treatments are tailored to individual patients, has boosted the development of medical patches that offer controlled and targeted drug delivery. This customization allows for better patient outcomes and improved therapeutic efficacy. For instance, in 2020, Reddy’s Laboratories launched an authorized generic version of NitroDur (nitroglycerin) transdermal infusion system in the US market. With the growing emphasis on home healthcare and remote patient monitoring, medical patches offer a convenient solution for delivering medications and monitoring vital signs outside traditional healthcare settings. The US transdermal drug delivery system market is influenced by factors such as the increasing prevalence of chronic diseases, rising technological advancements, and growing focus on personalized medicines.
A few of the major primary and secondary sources referred to while preparing the report on the transdermal drug delivery systems market are the World Bank Data, National Health Service (NHS), FDA (Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization).
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to our latest study on “Transdermal Drug Delivery Systems Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis” the market is expected to grow from US$ 37.230 billion in 2022 and is expected to reach US$ 51.949 billion by 2030; it is anticipated to record a CAGR of 4.3% from 2022 to 2030. The report highlights the key factors driving the transdermal drug delivery systems market growth and prominent players with their developments in the market.
Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient’s skin. It is a type of medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal drug delivery systems deliver the drug at a controlled rate to the systemic circulation.
Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022–2030. A transdermal patch is a drug delivery system attached to a patient’s skin to deliver medication through the skin. The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application. The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. The central nervous system disorders segment is expected to register the highest CAGR in the market during 2022–2030. Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022–2030.
Novartis AG, Johnson & Johnson, GSK Plc, Viatris Inc, Boehringer Ingelheim International GmbH, Luye Pharma Group Ltd, Hisamitsu Pharmaceutical Co Inc, Lavipharm SA, Purdue Pharma LP, and UCB SA are among the leading companies operating in the global Transdermal Drug Delivery Systems market.
Companies operating in the transdermal drug delivery systems market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the transdermal drug delivery systems market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall transdermal drug delivery systems market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
A few of the significant developments by key market players are listed below.
• In October 2023, Novartis completed the Spin-off of Sandoz, its Generics and Biosimilars business. Novartis executed the separation of the Sandoz business to create an independent company by way of a 100% Spin-off.
• In December 2022, Luye Pharma Group held an offline product launch conference in Shanghai, together with an online event, to announce the launch of Ruoxinlin (Toludesvenlafaxine Hydrochloride Extended-Release Tablets) in China. Ruoxinlin is China’s first-class 1 innovative chemical drug independently developed locally for the treatment of Major Depressive Disorder (MDD) and protected by intellectual property rights. The drug provides a powerful new option for patients, bringing the treatment of MDD to a new level.
• In February 2021, Luye Pharma Group announced that its subsidiary Luye Pharma Switzerland AG has entered into an agreement with Towa Pharmaceutical Co Ltd (Towa), the terms of which grant Towa exclusive rights to the development and commercialization of Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) in Japan. Rivastigmine MD, created by Luye Pharma, uses a cutting-edge drug delivery technology through twice-weekly transdermal application to treat Alzheimer’s disease. A number of foreign patents have been applied for and granted to Luye Pharma to protect this product. Rivastigmine MD is presently in the registration stage in Europe and will soon begin phase III clinical research there. The deal states that Luye Pharma has given Towa exclusive rights to create and market Rivastigmine MD in Japan.
• In January 2021, Luye Pharma Group held a press conference to announce the launch of its Rivastigmine Transdermal Patch in China. The medication is approved for the treatment of mild to moderate Alzheimer’s disease and should be used topically once daily. The company’s German affiliate Luye Pharma AG, created the item using its unique transdermal patch technology. In addition to China, the United States, 11 nations in Europe, Thailand, and other nations have all sold Rivastigmine Transdermal Patch by Luye Pharma AG.
• In December 2019, Hisamitsu Pharmaceutical Co. Inc launched HARUROPI TAPE, a transdermal Parkinson’s disease treatment patch in Japan, on December 17, 2019, following the National Health Insurance (NHI) drug price listing on November 19, 2019.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the transdermal drug delivery systems market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global transdermal drug delivery systems market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the transdermal drug delivery systems market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Transdermal Drug Delivery System Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Transdermal Drug Delivery System Market Landscape
4.1 Overview
4.2 Global PEST Analysis
5. Transdermal Drug Delivery System Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Demand for Noninvasive Drug Delivery Devices
5.1.3 High Demand for Self-Administration of Drugs
5.2 Market Restraints
5.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
5.3 Market Opportunities
5.3.1 Advancements in Smart Patches and 3D-Printed Patches
5.4 Future Trends
5.4.1 Strategic Initiatives by Manufacturers
5.5 Impact Analysis
6. Transdermal Drug Delivery System Market – Global Market Analysis
6.1 Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 – 2030
7. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
7.3 Transdermal Patches
7.3.1 Overview
7.3.2 Transdermal Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Drug-in-Adhesive Patches
7.3.2.1.1 Overview
7.3.2.1.2 Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Matrix Patches
7.3.2.2.1 Overview
7.3.2.2.2 Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.3 Reservoir Membrane Patches
7.3.2.3.1 Overview
7.3.2.3.2 Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.4 Vapor Patches
7.3.2.4.1 Overview
7.3.2.4.2 Vapor Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Transdermal Gels
7.4.1 Overview
7.4.2 Transdermal Gels: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Transdermal Sprays
7.5.1 Overview
7.5.2 Transdermal Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Cardiovascular Diseases
8.3.1 Overview
8.3.2 Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Central Nervous System Disorders
8.4.1 Overview
8.4.2 Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Pain Management
8.5.1 Overview
8.5.2 Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Opioid
8.5.2.1.1 Overview
8.5.2.1.2 Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.5.2.2 Non-Opioid
8.5.2.2.1 Overview
8.5.2.2.2 Non-Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Hormonal Applications
8.6.1 Overview
8.6.2 Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.1 Transdermal Estrogen & Progesterone Therapy
8.6.2.1.1 Overview
8.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.6.2.2 Testosterone Replacement
8.6.2.2.1 Overview
8.6.2.2.2 Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Other Application
8.7.1 Overview
8.7.2 Other Application: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10. Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 – Geographic Analysis
10.1 North America: Transdermal Drug Delivery System Market
10.1.1 Overview
10.1.2 North America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.3 North America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.3.1 North America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.4 North America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.4.1 North America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.4.2 North America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5 North America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.1 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.1 Overview
10.1.5.1.2 US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.1.3 US: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.1.3.1 US: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.1.4 US: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.1.4.1 US: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.1.4.2 US: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.1.5 US: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.1 Overview
10.1.5.2.2 Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.2.3 Canada: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.2.3.1 Canada: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.2.4 Canada: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.2.4.1 Canada: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.2.4.2 Canada: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.2.5 Canada: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.1.5.3 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.1 Overview
10.1.5.3.2 Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.1.5.3.3 Mexico: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.1.5.3.3.1 Mexico: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.1.5.3.4 Mexico: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.1.5.3.4.1 Mexico: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.1.5.3.4.2 Mexico: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.1.5.3.5 Mexico: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2 Europe: Transdermal Drug Delivery System Market
10.2.1 Overview
10.2.2 Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.3 Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.3.1 Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.4 Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.4.1 Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.4.2 Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.5 Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6 Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.2.6.1 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.1.3 Germany: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.1.3.1 Germany: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.1.4 Germany: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.1.4.1 Germany: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.1.4.2 Germany: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.1.5 Germany: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.2.3 France: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.2.3.1 France: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.2.4 France: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.2.4.1 France: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.2.4.2 France: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.2.5 France: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.3 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.3.3 UK: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.3.3.1 UK: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.3.4 UK: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.3.4.1 UK: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.3.4.2 UK: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.3.5 UK: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.4 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.4.3 Italy: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.4.3.1 Italy: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.4.4 Italy: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.4.4.1 Italy: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.4.4.2 Italy: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.4.5 Italy: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.5 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.5.3 Spain: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.5.3.1 Spain: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.5.4 Spain: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.5.4.1 Spain: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.5.4.2 Spain: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.5.5 Spain: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.2.6.6 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.2.6.6.3 Rest of Europe: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.2.6.6.4 Rest of Europe: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.2.6.6.4.1 Rest of Europe: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.2.6.6.4.2 Rest of Europe: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.2.6.6.5 Rest of Europe: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3 Asia Pacific: Transdermal Drug Delivery System Market
10.3.1 Overview
10.3.2 Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.3 Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.3.1 Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.4 Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.4.1 Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.4.2 Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.5 Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6 Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
10.3.6.1 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.1.3 China: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.1.3.1 China: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.1.4 China: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.1.4.1 China: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.1.4.2 China: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.1.5 China: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.2.3 Japan: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.2.3.1 Japan: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.2.4 Japan: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.2.4.1 Japan: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.2.4.2 Japan: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.2.5 Japan: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.3 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.3.3 India: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.3.3.1 India: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.3.4 India: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.3.4.1 India: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.3.4.2 India: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.3.5 India: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.4 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.4.3 Australia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.4.3.1 Australia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.4.4 Australia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.4.4.1 Australia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.4.4.2 Australia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.4.5 Australia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.5 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.5.3 South Korea: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.5.3.1 South Korea: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.5.4 South Korea: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.5.4.1 South Korea: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.5.4.2 South Korea: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.5.5 South Korea: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.3.6.6.3.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.3.6.6.4.1 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.3.6.6.4.2 Rest of Asia Pacific: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4 Middle East & Africa Transdermal Drug Delivery System Market
10.4.1 Overview
10.4.2 Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.3 Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.3.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.4 Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.4.1 Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.4.2 Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5 Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.1 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.1 Overview
10.4.5.1.2 South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.1.3 South Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.1.3.1 South Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.1.4 South Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.1.4.1 South Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.1.4.2 South Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.1.5 South Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.2.3 Saudi Arabia: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.2.3.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.2.4 Saudi Arabia: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.2.4.1 Saudi Arabia: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.2.4.2 Saudi Arabia: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.2.5 Saudi Arabia: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.3 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.1 Overview
10.4.5.3.2 UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.3.3 UAE: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.3.3.1 UAE: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.3.4 UAE: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.3.4.1 UAE: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.3.4.2 UAE: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.3.5 UAE: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.4.5.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.4.5.4.3 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.4.5.4.3.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.4.5.4.4 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.4.5.4.4.1 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.4.5.4.4.2 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.4.5.4.5 Rest of Middle East & Africa: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5 South & Central America: Transdermal Drug Delivery System Market
10.5.1 Overview
10.5.2 South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.3 South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.3.1 South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.4 South & Central America: Transdermal Drug Delivery System Market, By Application, 2020–2030 (US$ Million)
10.5.4.1 South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.4.2 South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.5 South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel, 2020–2030 (US$ Million)
10.5.6 South & Central America: Transdermal Drug Delivery System Market Share by Country – 2022 & 2030, (%)
10.5.6.1 Brazil: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.1.1 Overview
10.5.6.2 Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.2.1 Brazil: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.2.1.1 Brazil: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.2.2 Brazil: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.2.2.1 Brazil: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.2.2.2 Brazil: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.2.3 Brazil: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.3 Argentina: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.3.1 Overview
10.5.6.4 Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
10.5.6.4.1 Argentina: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.4.1.1 Argentina: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.4.2 Argentina: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.4.2.1 Argentina: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.4.2.2 Argentina: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.4.3 Argentina: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
10.5.6.5 Rest of South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.5.1 Overview
10.5.6.6 Rest of South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
10.5.6.6.1 Rest of South & Central America: Transdermal Drug Delivery System Market, by Product, 2020–2030 (US$ Million)
10.5.6.6.1.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Transdermal Patches by Product, 2020–2030 (US$ Million)
10.5.6.6.2 Rest of South & Central America: Transdermal Drug Delivery System Market, by Application, 2020–2030 (US$ Million)
10.5.6.6.2.1 Rest of South & Central America: Transdermal Drug Delivery System Market, For Pain Management by Application, 2020–2030 (US$ Million)
10.5.6.6.2.2 Rest of South & Central America: Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020–2030 (US$ Million)
10.5.6.6.3 Rest of South & Central America: Transdermal Drug Delivery System Market, by Distribution Channel, 2020–2030 (US$ Million)
11. Transdermal Drug Delivery System Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Transdermal Drug Delivery System Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Novartis AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Johnson & Johnson
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GSK Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Viatris Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Boehringer Ingelheim International GmbH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Hisamitsu Pharmaceutical Co Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Luye Pharma Group Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lavipharm SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Purdue Pharma LP
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 UCB SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Transdermal Drug Delivery System Market Segmentation
Table 2. North America Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. North America Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. North America Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 9. US Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. US Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. US Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. US Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. US Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 21. Mexico Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 26. Europe Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 27. Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 28. Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 29. Europe Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 30. Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. Europe Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 32. Germany Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 33. Germany Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 34. Germany Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 35. Germany Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 36. Germany Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 37. Germany Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 38. France Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 39. France Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 40. France Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 41. France Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 42. France Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 43. France Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 44. UK Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 45. UK Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 46. UK Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 47. UK Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 48. UK Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 49. UK Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 50. Italy Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 51. Italy Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 52. Italy Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 53. Italy Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 54. Italy Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 55. Italy Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 56. Spain Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 57. Spain Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 58. Spain Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 59. Spain Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 60. Spain Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 61. Spain Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 62. Rest of Europe Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 63. Rest of Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 64. Rest of Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 65. Rest of Europe Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 66. Rest of Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 67. Rest of Europe Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 68. Asia Pacific Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 69. Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 70. Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 71. Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 72. Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 73. Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 74. China Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 75. China Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 76. China Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 77. China Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 78. China Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 79. China Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 80. Japan Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 81. Japan Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 82. Japan Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 83. Japan Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 84. Japan Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 85. Japan Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 86. India Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 87. India Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 88. India Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 89. India Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 90. India Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 91. India Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 92. Australia Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 93. Australia Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 94. Australia Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 95. Australia Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 96. Australia Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 97. Australia Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 98. South Korea Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 99. South Korea Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 100. South Korea Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 101. South Korea Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 102. South Korea Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 103. South Korea Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 104. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 105. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 106. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 107. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 108. Rest of Asia Pacific Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 109. Rest of Asia Pacific Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 110. Middle East & Africa Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 111. Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 112. Middle East & Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 113. Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 114. Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 115. Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 116. South Africa Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 117. South Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 118. South Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 119. South Africa Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 120. South Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 121. South Africa Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 122. Saudi Arabia Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 123. Saudi Arabia Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 124. Saudi Arabia Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 125. Saudi Arabia Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 126. Saudi Arabia Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 127. Saudi Arabia Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 128. UAE Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 129. UAE Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 130. UAE Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 131. UAE Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 132. UAE Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 133. UAE Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 134. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 135. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 136. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 137. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 138. Rest of Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 139. Rest of Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 140. South & Central America: Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 141. South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 142. South & Central America: Transdermal Drug Delivery System Market, By Application – Revenue and Forecast to 2030 (US$ Million)
Table 143. South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 144. South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 145. South & Central America: Transdermal Drug Delivery System Market, By Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 146. Brazil Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 147. Brazil Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 148. Brazil Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 149. Brazil Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 150. Brazil Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 151. Brazil Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 152. Argentina Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 153. Argentina Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 154. Argentina Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 155. Argentina Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 156. Argentina Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 157. Argentina Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 158. Rest of South & Central America Transdermal Drug Delivery System Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 159. Rest of South & Central America Transdermal Drug Delivery System Market, For Transdermal Patches by Product – Revenue and Forecast to 2030 (US$ Million)
Table 160. Rest of South & Central America Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 161. Rest of South & Central America Transdermal Drug Delivery System Market, For Pain Management by Application – Revenue and Forecast to 2030 (US$ Million)
Table 162. Rest of South & Central America Transdermal Drug Delivery System Market, For Hormonal Applications by Application – Revenue and Forecast to 2030 (US$ Million)
Table 163. Rest of South & Central America Transdermal Drug Delivery System Market, by Distribution Channel – Revenue and Forecast to 2030 (US$ Million)
Table 164. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 165. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 166. Glossary of Terms, Transdermal Drug Delivery System Market
LIST OF FIGURES
Figure 1. Transdermal Drug Delivery System Market Segmentation, By Geography
Figure 2. Global – PEST Analysis
Figure 3. Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 4. Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 5. Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 – 2030
Figure 6. Global Transdermal Drug Delivery System Market, By Geography Forecast Analysis, 2022 & 2030
Figure 7. Transdermal Drug Delivery System Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. Transdermal Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Drug-in-Adhesive Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Matrix Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Reservoir Membrane Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Vapor Patches: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Transdermal Gels: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Transdermal Sprays: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Non-Opioid: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Transdermal Estrogen & Progesterone Therapy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Testosterone Replacement: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Other Application: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 27. Hospital Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Retail Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Online Pharmacies: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Others: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 32. North America Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. North America: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 34. US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Europe: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. Europe Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. Europe: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 40. Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. Rest of Europe: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Asia Pacific: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 47. Asia Pacific Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)
Figure 48. Asia Pacific: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 49. China: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 50. Japan: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. India: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. Australia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. South Korea: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. Rest of Asia Pacific: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 55. Middle East & Africa: Transdermal Drug Delivery System Market, by Key Country – Revenue (2022) (US$ Million)
Figure 56. Middle East & Africa Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 57. Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 58. South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 59. Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 61. Rest of Middle East & Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 62. South & Central America: Transdermal Drug Delivery System Market, By Key Country – Revenue (2022) (US$ Million)
Figure 63. South & Central America: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 64. South & Central America: Transdermal Drug Delivery System Market Share by Country – 2022 & 2030, (%)
Figure 65. Brazil: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 66. Argentina: Transdermal Drug Delivery System Market- Revenue and Forecasts to 2030 (US$ Million)
Figure 67. Rest of South & Central America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2030 (US$ Million)
Figure 68. Growth Strategies in the Transdermal Drug Delivery System Market
The List of Companies – Transdermal Drug Delivery System Market
o Novartis AG Â
o Johnson & Johnson
o GSK Plc
o Viatris Inc Â
o Boehringer Ingelheim International GmbH
o Hisamitsu Pharmaceutical Co Inc
o Luye Pharma Group Ltd
o Lavipharm SA
o Purdue Pharma LP
o UCB SA
You must be logged in to post a review.
Reviews
There are no reviews yet.